Company & Sponsor Intelligence

University of Alabama at Birmingham

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting3

Completed8

Countries2

Therapeutic footprint

adhddementia_otherdepressionepilepsymultiple_sclerosisother_psychiatryparkinsonsstroke

Indexed studies

NCT03353688Biomarkers to Guide Directional DBS for Parkinson's Disease
parkinsons · United StatesNA

NCT03122288Individualized Cognitive Training in HIV
dementia_other · United StatesNA

NCT03490240Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis
multiple_sclerosis · United StatesNA

NCT07661524Passive Versus Active Music Therapy Parkinson's Disease
parkinsons · United StatesNA

NCT01113684Study of Subthalamic Brain Stimulation in Parkinson Disease (PD)
parkinsons · United StatesCOMPLETED

NCT04990687Vagal Nerve Stimulation for Treatment Resistant Major Depression
depression · United StatesNA

NCT05121064Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia
other_psychiatry · ZambiaNA

NCT03495193Impact of Exercise in Parkinson's Disease
parkinsons · United StatesNA

NCT00622427Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia
adhd · United StatesPHASE4

NCT04740060Effects of Different Types of Augmented Feedback on Intrinsic Motivation and Spatiotemporal Gait Performance After Stroke
stroke · United StatesNA

NCT06570954Retraining and Control Therapy (ReACT)- Adults
epilepsy · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →